Vertex Pharmaceuticals · 1 day ago
Global Health Economics & Outcomes Research (HEOR) Associate Director (HYBRID)
Vertex Pharmaceuticals is a global biotechnology company on the forefront of scientific innovation. They are seeking a talented and motivated individual for the role of HEOR Associate Director, responsible for shaping and executing HEOR strategies to optimize the value proposition for Vertex’s assets through various stages of development.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Leads execution of complex HEOR evidence generation studies, with focus on prospective and retrospective observational studies, COA strategy, and PRO measure development and validation, as well as systematic literature reviews, cost-effective analyses and budget impact models, indirect treatment comparisons, as needed, to support the asset value
Effectively leads external research partners to ensure robust scientific methods are applied to study design and execution and in compliance with all local regulations; is accountable for study design, data analysis and the quality of the evidence produced. Excellent project management is a pre-requisite to ensure studies delivered on time and within budget
Collaborates with the medical communications teams on publication strategy and ensure that dissemination of HEOR evidence is timely and has maximum impact
Partners and works closely with Global Pricing and Market Access to support development of product value proposition/value messaging and co-lead development of robust Global launch deliverables (e.g., global value dossier)
Qualification
Required
Strong track record of publication in peer-reviewed journals
Strong background in clinical outcome assessment (COA) measurement strategy; experience in PRO development/validation and qualitative research methodology
Technical expertise in HEOR with able to formulate and lead creative research projects and ensure conduct is technically and scientifically rigorous and reflects best HEOR practices; hands-on experience with prospective and site-based research is desired
Strong verbal and written communications skills, including presentation skills to communicate difficult concepts and persuade others; comfortable communicating complex concepts and adapting presentation style to a variety of audiences
Excellent project and people management skills to oversee vendors and internal project team, while aligning with cross-functional partners to ensure successful project execution, on timelines and budgets
Ability to apply knowledge of US healthcare system, global health technology appraisal requirements, and clinical development, to identify evidence gaps and formulate evidence generation strategies
Understanding of the legal and regulatory environment of the pharmaceutical industry, with spotless history of compliance and ethical workplace conduct
Advanced degree (PhD, MD, Master's degree, MPH, or PharmD) in a relevant discipline
Typically requires 8+ years of relevant experience, with substantial background in a Global HEOR role in a pharmaceutical/biotech setting, or the equivalent combination of education and experience
Benefits
Inclusive market-leading benefits
Medical, dental and vision benefits
Generous paid time off (including a week-long company shutdown in the Summer and the Winter)
Educational assistance programs including student loan repayment
A generous commuting subsidy
Matching charitable donations
401(k)
Company
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
H1B Sponsorship
Vertex Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (188)
2024 (150)
2023 (111)
2022 (164)
2021 (112)
2020 (80)
Funding
Current Stage
Public CompanyTotal Funding
$657.31MKey Investors
Janssen Belgium
2024-07-10Post Ipo Secondary· $1.11M
2022-05-17Post Ipo Equity· $50M
2009-12-03Post Ipo Equity· $443M
Leadership Team
Recent News
2026-01-23
Benzinga.com
2026-01-23
2026-01-22
Company data provided by crunchbase